CHALLENGES TO INDIANBIOTECHNOLOGICAL RESEARCH

ANDINDUSTRIES.

AJINDER AND SWATI8013 ,8011

MSC.BIOTECHNOLOGY

Contents

Biotechnology and India Indian market SWOT analysis Challenges faced Biotech business in India Ipr &biotech industry Future of Indian biotech sector

BIOTECHNOLOGY AND INDIA

Quite nascent stage.

Biodiversity of India is an advantage for

biotech sector.

Over 300 registered biotech companies, out

of which 100 are in modern biotech sector.

12th most successful biotech sector in world,

3rd largest in Asia with 96 enterprises(after

Australia and china).

INDIAN BIOTECH MARKET

Total biotech sectors: $420 million in

2002-03.

Vaccines : bharat biotech, shanta

biotech,pfizer, panacea,etc.

Therapeutics : biocon, eli lily, etc.

Diagnostics : span diagnostics,j.mitra,

xcyton

SWOT ANALYSIS

Strength, weakness , opportunity,

threats,

Best way to make critical analysis of

scientific research in country.

STRENGTH:

Human Resource: Trained manpower and knowledge base. •Academic Resource: Good network of research laboratories. •Industry Base: Well developed base industries (e.g.

pharmaceuticals, seeds). •International Experts: Access to intellectual resources of NRI’s

in this area. •Clinical Capability: Extensive clinical trials and research access

to vast and diverse disease in the huge population. •Bio-diversity: India’s human gene pools and unique plant,

animal & microbial diversity offer an exciting opportunity for genomic research.

•Stem Cells Research: Several labs have commenced research in stem cells and have valuable stem cell lines.

Weakness

Indian Biotechnology: Weakness

Missing link between research and

commercialization

•Lack of venture capital

•Relatively low R&D expenditure by industry

•Image of Indian industry –doubts about ability

of Indian products to meet International

standards of quality

Opportunitiesindian Biotechnology: Opportunities

•Large domestic market •Large export potential •Low cost research base for international companies in comparison

with other countries •Vast and diverse disease based patient populations provide unique

opportunities for clinical research and clinical trials •Supportive Government policy on embryonic stem cells research

provides a useful opportunity for International companies to pursue such research in India

•Human bio-diversity provides unique research opportunity in genomics

•Plant & microbial bio-diversity provides vast prospecting opportunities for new drugs

•Conducive Government policy on GM crops provides useful opportunities for Agri-biotech companies

Threats

Exodus of brilliant brain to other

countries.

Enhanced level of politics in system.

Improper utilization of enormous funds.

Lack of scientific responsibility among

young scientist.

Challenges faced by indian biotechnological sector

Weak entrepreneurial skills

Lack of quality human resource

Lack of public private partnership.

Risk averse nature of industry.

Lack of venture funding

Lack of ignition grant system.

Streamlining the regulatory process.

Time to market.

Poor feasibility of indian market.

Partnership with pharmaceutical

industry.

Business in india

Joint venture Collaborative research. Contract research Technology transfer Clinical research.

IPR and the Biotech Industry

Ipr importance•IP is a central issue in any industry•Robust intellectual property rights framework is the

need of the hour•India is already member of –Paris Convention–PCT–Berne Convention–Convention on biological diversity–WTO•Should make legislation clear on the criteria for the

patentability of biotechnological inventions

Ipr scenario in India(challenges):

need to improve patent legislation infrastructure needs attention till 2005 only process were granted

patent. poor patent protection & litigation

attracts less foreign ventures. inefficient indian judicial system.

What can be Claimed?

–Diagnostic tests –Research tools –Gene therapy –Therapeutic proteins Sensors –Bioinformatics –Sequences –Pharmaceuticals

The future of Biotechnology

•Developing diverse, collaborative relationships to strengthen its industry

•Harmonizing standards with international standards in manufacturing and

laboratory practices (ensuring foreign markets and enhancement of the

industry’s global and local standing)

•Cheaper labor, technical capacity and expertise may capture markets

away from companies in the developed countries

•Illustrates the importance of fostering a regulatory and IP environment

(encouraging innovative startup companies)

THANK YOU!!!!